GoodRx published a list of the 20 most expensive drugs in the U.S. Aug. 11, including only medications filled at pharmacies that patients can self-administer on a regular basis. It posted another ranking of the 10 most expensive drugs in the country Aug. 25, including both drugs dispensed at pharmacies and those that must be administered by a healthcare provider.
The 10 most expensive drugs in the U.S. based on their annual list prices:
- Zolgensma — $2,125,000 (AveXis)
- Myalept — $855,678 (Amryt Pharma)
- Luxturna — $850,000 (Spark Therapeutics)
- Folotyn — $793,870 (Acrotech Biopharma)
- Brineura — $716,040 (BioMarin Pharmaceuticals)
- Soliris — $678,392 (Alexion Pharmaceuticals)
- Blincyto — $672,968 (Amgen)
- Ravicti — $664,092 (Horizon Therapeutics)
- Lumizyme — $643,243 (Sanofi Genzyme)
- Actimmune — $633,325 (Horizon Therapeutics)
More articles on pharmacy:
Biogen conference may have led to 20,000 COVID-19 infections, researchers say
AbbVie, Harvard partner to study coronavirus therapies
Patients over 50 may take meds less if pill appearance changes a lot, study says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
